Epigenetic inactivation of connexin 32 in renal cell carcinoma from hemodialytic patients [1]

Kidney International

Volumn 65, Issue 4, 2004, Pages 1519-

  Yano, Tomohiro ^a   Ito, Fumio ^b   Yamasaki, Hiroshi ^b   Hagiwara, Kiyokazu ^b   Ozasa, Hisashi ^b   Nakazawa, Hayakazu ^b   Toma, Hiroshi ^b  

^a NATIONAL INSTITUTE OF HEALTH AND NUTRITION   (Japan)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CONNEXIN 32;

CANCER RISK; CARCINOGENESIS; CPG ISLAND; DOWN REGULATION; EPIGENETICS; GAP JUNCTION; GENE DELETION; GENE MUTATION; HEMODIALYSIS; HUMAN; KIDNEY CARCINOMA; KIDNEY CYST; KIDNEY TUBULE; LETTER; LONG TERM CARE; METHYLATION; PRIORITY JOURNAL; STEM CELL; TUMOR SUPPRESSOR GENE;

EID: 1642422292     PISSN: 00852538     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1523-1755.2004.555_1.x     Document Type: Letter

References (4)

1. CHOYKE PL: Acquired cystic kidney disease. Eur Radiol 10:1716-1721, 2000
2. YANO T, ITO F, SATOH H, et al: Tumor-suppressive effect of connexin 32 in renal cell carcinoma from maintenance hemodialysis patients. Kidney Int 63:381, 2003
3. BAYLIN SB, HERMAN JG, GRAFF JR, et al: Alteration in DNA methylation: A fundamental aspect of neoplasia. Adv Cancer Res 72:141-196, 1998
4. YANO T, ITO F, YAMASAKI H, et al: Hypermethylation of the CpG island of connexin 32, a candidate tumor suppressor gene in renal cell carcinomas from hemodialysis patients. Cancer Lett 2004, in press